Skip to main content
C&R Research Inc. logo

C&R Research Inc. — Investor Relations & Filings

Ticker · 359090 ISIN · KR7359090008 KO Professional, scientific and technical activities
Open in API
Filings indexed 163 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 359090

About C&R Research Inc.

https://www.cnrres.com/

C&R Research Inc. is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. The company's offerings span the entire product lifecycle, from early-phase development and clinical trial design to regulatory affairs, data management, statistical consulting, and trial management. C&R Research is actively transitioning into a 'Data CRO' by integrating artificial intelligence (AI), Real-World Data (RWD), and platform-based solutions to enhance the efficiency and quality of clinical trials. The organization supports global studies, including navigating regulatory submissions with international bodies such as the U.S. FDA, and has demonstrated expertise in complex therapeutic areas like oncology, advanced biologics, and innovative medical devices.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 88% confidence The document is titled "분기보고서 (제 7 기) 2026년 01월 01일~2026년 03월 31일" and contains comprehensive sections typical of a quarterly (interim) report: company overview, business descriptions, capital changes, share statistics, and is clearly the full report itself rather than an announcement. It contains substantive financial and operational information for a quarter, satisfying the criteria for an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Korean
임시주주총회결과
Regulatory Filings
2026-05-07 Korean
불성실공시법인지정 (공시불이행 1건, 공시변경 1건)
Regulatory Filings
2026-05-06 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 90% confidence The document is clearly a Notice of Convocation for the 7th Extraordinary General Meeting (임시주주총회 소집공고) of C&R Research Co., Ltd., providing shareholders with the meeting date, location, agenda items (including share consolidation and amendments to the articles), detailed background information and materials to enable informed voting. This matches the description of materials sent to shareholders to provide information and solicit votes for a meeting (Proxy Solicitation & Information Statement).
2026-04-22 Korean
불성실공시법인지정예고 (공시불이행 1건, 공시변경 1건)
Regulatory Filings Classification · 85% confidence The document is a preliminary notice of designation as an ‘unfaithful disclosure corporation’ under KOSDAQ market disclosure rules, detailing types of missed or amended disclosures with reference to regulatory provisions. It is not a financial report itself but a regulatory announcement of non-compliance, fitting the fallback category for miscellaneous regulatory filings.
2026-04-10 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.